Basic Information
| RNALocate ID: | RLID:11004306 |
| RNA Symbol: | hsa-miR-1294 |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-1294 |
| RNA ID: | miRBase:MIMAT0005884 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11004307 | Microvesicle | Serum | 24797360 |
| RLID-D:11000769 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells | |
| RLID-D:11001683 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-mir-1294 | Oral squamous cell carcinoma | MNDR-E-MI-09879 |
| MNDR | hsa-miR-1294 | Estrogen-receptor positive breast cancer | MNDR-E-MI-09880 |
| MNDR | hsa-miR-1294 | Estrogen-receptor negative breast cancer | MNDR-E-MI-09881 |
| MNDR | hsa-miR-1294 | Progesterone-receptor positive breast cancer | MNDR-E-MI-09882 |
| MNDR | hsa-miR-1294 | Progesterone-receptor negative breast cancer | MNDR-E-MI-09883 |
| MNDR | hsa-miR-1294 | Her2-receptor positive breast cancer | MNDR-E-MI-09884 |
| MNDR | hsa-miR-1294 | Prostate cancer | MNDR-E-MI-09885 |
| MNDR | hsa-miR-1294 | Gastric cancer | MNDR-E-MI-09886 |
| MNDR | hsa-miR-1294 | Alzheimer disease | MNDR-E-MI-09887 |
| MNDR | hsa-miR-1294 | Lung cancer | MNDR-E-MI-09888 |
| MNDR | hsa-miR-1294 | Parkinson disease | MNDR-E-MI-09889 |
| MNDR | hsa-miR-1294 | Breast cancer | MNDR-E-MI-09890 |
| MNDR | hsa-mir-1294 | Squamous cell carcinoma | MNDR-E-MI-09891 |
| MNDR | hsa-miR-1294 | Pancreatic cancer | MNDR-E-MI-09892 |
| MNDR | hsa-miR-1294 | Nephroblastoma | MNDR-E-MI-09893 |
| MNDR | hsa-miR-1294 | Colon cancer | MNDR-E-MI-09894 |
| MNDR | hsa-miR-1294 | Familial ovarian cancer | MNDR-E-MI-09895 |
| MNDR | hsa-mir-1294 | Glioma | MNDR-E-MI-09896 |
| MNDR | hsa-miR-1294 | Chronic obstructive pulmonary disease | MNDR-E-MI-09897 |
| MNDR | hsa-miR-1294 | Lung adenocarcinoma | MNDR-E-MI-09898 |
| MNDR | hsa-miR-1294 | Cholangiocarcinoma | MNDR-E-MI-09899 |
| MNDR | hsa-miR-1294 | Hepatocellular carcinoma | MNDR-E-MI-09900 |
| MNDR | hsa-miR-1294 | Familiar ovarian carcinoma | MNDR-E-MI-09901 |
| MNDR | hsa-miR-1294 | Neuromyelitis optica | MNDR-E-MI-09902 |
| MNDR | hsa-miR-1294 | Colorectal cancer | MNDR-E-MI-09903 |
| MNDR | hsa-miR-1294 | Nasopharynx carcinoma | MNDR-E-MI-09904 |
| MNDR | hsa-mir-1294 | Esophageal squamous cell carcinoma | MNDR-E-MI-09905 |
| MNDR | hsa-miR-1294 | Nasopharyngeal cancer | MNDR-E-MI-09906 |
| MNDR | hsa-miR-1294 | Cerebral hemorrhage traumatic | MNDR-E-MI-09907 |
| MNDR | hsa-miR-1294 | Intracranial hemorrhage hypertensive | MNDR-E-MI-09908 |
| MNDR | hsa-miR-1294 | Chronic pain | MNDR-E-MI-09909 |
| MNDR | hsa-miR-1294 | Breast cancer her3+ negative | MNDR-E-MI-09910 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | MYC | Homo sapiens | RR00950980 |
TOP